The stock of Doximity Inc (NYSE: DOCS) has decreased by -4.83 when compared to last closing price of 61.34. Despite this, the company has experienced a -0.44% fall in its stock price over the last five trading sessions. zacks.com reported 2025-06-27 that Doximity (DOCS) concluded the recent trading session at $61.09, signifying a +1.13% move from its prior day’s close.
Is It Worth Investing in Doximity Inc (NYSE: DOCS) Right Now?
Doximity Inc (NYSE: DOCS) has a higher price-to-earnings ratio of 52.71x compared to its average ratio. DOCS has 36-month beta value of 1.37. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 11 as “hold,” and 0 as “sell.”
The public float for DOCS is 132.76M, and currently, short sellers hold a 4.21% ratio of that float. The average trading volume of DOCS on July 02, 2025 was 2.56M shares.
DOCS’s Market Performance
The stock of Doximity Inc (DOCS) has seen a -0.44% decrease in the past week, with a 12.08% rise in the past month, and a 0.60% gain in the past quarter. The volatility ratio for the week is 3.29%, and the volatility levels for the past 30 days are at 3.14% for DOCS. The simple moving average for the past 20 days is 0.82% for DOCS’s stock, with a 6.41% simple moving average for the past 200 days.
Analysts’ Opinion of DOCS
Many brokerage firms have already submitted their reports for DOCS stocks, with BTIG Research repeating the rating for DOCS by listing it as a “Buy.” The predicted price for DOCS in the upcoming period, according to BTIG Research is $80 based on the research report published on June 02, 2025 of the current year 2025.
Piper Sandler, on the other hand, stated in their research note that they expect to see DOCS reach a price target of $78, previously predicting the price at $31. The rating they have provided for DOCS stocks is “Overweight” according to the report published on February 07th, 2025.
Leerink Partners gave a rating of “Outperform” to DOCS, setting the target price at $90 in the report published on February 07th of the current year.
DOCS Trading at 3.43% from the 50-Day Moving Average
After a stumble in the market that brought DOCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.49% of loss for the given period.
Insider Trading
Benjamin Regina M., the Director of Doximity Inc, sale 10,000 shares at $60.00 during a trade that took place back on Jun 25 ’25, which means that Benjamin Regina M. is holding 16,618 shares at $600,000 based on the most recent closing price.
Stock Fundamentals for DOCS
Current profitability levels for the company are sitting at:
- 0.4 for the present operating margin
- 0.9 for the gross margin
The net margin for Doximity Inc stands at 0.39. The total capital return value is set at 0.21. Equity return is now at value 22.50, with 18.93 for asset returns.
Based on Doximity Inc (DOCS), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 22.04.
Currently, EBITDA for the company is 240.76 million with net debt to EBITDA at -0.82. When we switch over and look at the enterprise to sales, we see a ratio of 18.88. The receivables turnover for the company is 4.44for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.92.
Conclusion
To put it simply, Doximity Inc (DOCS) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
